Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00595582 · ClinicalTrials.gov registry record · NA
Early Intervention in Mild Cognitive Impairment (MCI) With Curcumin + Bioperine
A NA study, sponsored by Louisiana State University Health Sciences Center Shreveport.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT00595582 is a NA study that was terminated before completion, run by Louisiana State University Health Sciences Center Shreveport. The registered enrollment target is 10 participants.
The verdict
NCT00595582, a NA study, was terminated before completion, sponsored by Louisiana State University Health Sciences Center Shreveport.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is an additional study to the primary Mild Cognitive Impairment (MCI) study (LSU#H04-049; NCT00243451)that is underway of PET detection of Mild Cognitive Impairment. This study has preliminary data that indicates objective analysis of PET brain image metabolic data is a sensitive marker for AD. The goal of this proposal is to determine the efficacy of curcumin in the treatment of MCI or mild Alzheimer's Disease (AD).
Interventions
- DIETARY_SUPPLEMENT curcumin + bioperine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-05 |
| Est. Completion | 2008-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00595582
The ClinicalTrials.gov registry entry for NCT00595582 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University Health Sciences Center Shreveport, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which curcumin + bioperine is the first listed.
NCT00595582 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00595582 about?
NCT00595582 is a clinical study titled "Early Intervention in Mild Cognitive Impairment (MCI) With Curcumin + Bioperine". This is an additional study to the primary Mild Cognitive Impairment (MCI) study (LSU#H04-049; NCT00243451)that is underway of PET detection of Mild Cognitive Impairment. This study has preliminary data that indicates objective analysis of PET brain image metabolic data is a sensitive marker for AD....
What is the current status of trial NCT00595582?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2005-05. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00595582?
The interventions under investigation include: curcumin + bioperine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00595582?
This trial is sponsored by Louisiana State University Health Sciences Center Shreveport, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.